The Swiss drugmaker expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.
Source link
Roche Forecasts 2026 Growth, Cites Drug-Pipeline Strength
Date:
More like thisRelated
Riley Green Has One Simple Reason for Not Buying His Own Album
Riley Green doesn't buy his own albums -- and honestly,...
Opinion | Republicans Are Running on Empty
The party’s panicky rush to ban diesel exports reveals...
NBA Rank 2026, players Nos. 100-51: Four rookies make their debuts
Signature stat: VanVleet ranks seventh in career assist-to-turnover ratio...